跨区域注册对标 / Cross-Region Benchmark
Companies and products registered in multiple regions (CDE + DMF + CEP)
Cross-Region Companies
540
CDE+DMF+CEP Triple
233
CDE+DMF Dual
445
CDE+CEP Dual
313
Cross-Region Products
1034 total, page 13 of 52| Product | CAS | CDE | DMF | CEP | Pattern | Action |
|---|---|---|---|---|---|---|
| Vildagliptin 维格列汀 | 274901-16-5 | 29 | 7 | - | CDE+DMF | View → |
| Loratadine 氯雷他定 | 79794-75-5 | 34 | 2 | - | CDE+DMF | View → |
| Pantoprazole Sodium 泮托拉唑钠（供口服用） | 102625-70-7 | 31 | 4 | - | CDE+DMF | View → |
| Nicorandil 尼可地尔（注射级） | 65141-46-0 | 33 | - | 1 | CDE+CEP | View → |
| Roxadustat 罗沙司他 | 808118-40-3 | 32 | 1 | - | CDE+DMF | View → |
| Apremilast 阿普斯特 | 608141-41-9 | 26 | 6 | - | CDE+DMF | View → |
| Azilsartan Medoxomil Potassium MY008211A | 863031-21-4 | 28 | 3 | - | CDE+DMF | View → |
| Palbociclib 帕博西尼 | 571190-30-2 | 24 | 7 | - | CDE+DMF | View → |
| Ibrutinib 伊布替尼 | 936563-96-1 | 23 | 8 | - | CDE+DMF | View → |
| Iguratimod 艾拉莫德 | 123663-49-0 | 30 | 1 | - | CDE+DMF | View → |
| Tirzepatide 酒石酸泰瑞西利 | 2023788-19-2 | 4 | 27 | - | CDE+DMF | View → |
| Bortezomib 硼替佐米 | 179324-69-7 | 24 | 7 | - | CDE+DMF | View → |
| Enzalutamide 氘恩扎鲁胺 | 915087-33-1 | 22 | 9 | - | CDE+DMF | View → |
| Esomeprazole Magnesium 埃索美拉唑镁 | 119141-88-7 | 30 | 1 | - | CDE+DMF | View → |
| Sugammadex Sodium 舒更葡糖钠 | 343306-71-8 | 24 | 7 | - | CDE+DMF | View → |
| Apalutamide 阿帕他胺 | 956104-40-8 | 22 | 8 | - | CDE+DMF | View → |
| Lanthanum Carbonate 碳酸镧 | 587-26-8 | 26 | 4 | - | CDE+DMF | View → |
| Ezetimibe 依折麦布 | 163222-33-1 | 24 | 5 | - | CDE+DMF | View → |
| Pemetrexed Disodium 培美曲塞二钠 | 137281-23-3 | 27 | 2 | - | CDE+DMF | View → |
| Linagliptin 利格列汀 | 668270-12-0 | 21 | 7 | - | CDE+DMF | View → |